Barclays Cuts Teladoc Health (NYSE:TDOC) Price Target to $7.00

Teladoc Health (NYSE:TDOC) had its price objective trimmed by Barclays from $8.50 to $7.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has an equal weight rating on the health services provider’s stock.

Other analysts have also recently issued reports about the stock. BMO Capital Markets reduced their price objective on shares of Teladoc Health from $8.00 to $5.00 and set a “market perform” rating for the company in a research note on Thursday, February 26th. Piper Sandler reaffirmed an “overweight” rating and issued a $9.00 target price (down from $12.00) on shares of Teladoc Health in a report on Thursday, February 26th. TD Cowen decreased their price target on Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a report on Thursday, February 26th. Deutsche Bank Aktiengesellschaft upgraded Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 price objective on the stock in a research report on Tuesday, March 10th. Finally, Canaccord Genuity Group dropped their price objective on Teladoc Health from $12.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Six research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $7.64.

Teladoc Health Stock Down 6.8%

TDOC stock opened at $5.15 on Thursday. The business’s 50-day moving average price is $5.28 and its 200-day moving average price is $6.89. The stock has a market cap of $917.87 million, a P/E ratio of -4.51 and a beta of 2.13. The company has a quick ratio of 2.67, a current ratio of 2.77 and a debt-to-equity ratio of 0.72. Teladoc Health has a twelve month low of $4.40 and a twelve month high of $9.77.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.05. Teladoc Health had a negative net margin of 7.92% and a negative return on equity of 9.13%. The company had revenue of $642.27 million during the quarter, compared to analyst estimates of $635.33 million. During the same period in the prior year, the firm posted ($0.28) EPS. The firm’s quarterly revenue was up .3% compared to the same quarter last year. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. On average, equities research analysts forecast that Teladoc Health will post -1.16 EPS for the current year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, CEO Charles Divita III sold 27,731 shares of Teladoc Health stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total value of $152,243.19. Following the sale, the chief executive officer directly owned 364,784 shares in the company, valued at approximately $2,002,664.16. The trade was a 7.06% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.58% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in TDOC. PNC Financial Services Group Inc. lifted its position in shares of Teladoc Health by 177.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after buying an additional 2,810 shares in the last quarter. IFP Advisors Inc increased its stake in Teladoc Health by 412.1% in the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after acquiring an additional 3,210 shares during the last quarter. Aster Capital Management DIFC Ltd increased its stake in Teladoc Health by 101.1% in the 3rd quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after acquiring an additional 2,425 shares during the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Teladoc Health during the 4th quarter worth approximately $45,000. Finally, Bayforest Capital Ltd purchased a new stake in shares of Teladoc Health during the 3rd quarter worth approximately $58,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.